ProfileGDS4718 / 235424_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 69% 64% 78% 69% 65% 72% 68% 74% 73% 70% 78% 60% 71% 70% 72% 75% 74% 67% 66% 70% 70% 73% 73% 68% 72% 70% 70% 65% 70% 59% 76% 69% 63% 74% 61% 63% 62% 74% 72% 80% 66% 69% 74% 64% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7886969
GSM549102patient 115, normal, homogenized [OPG study]6.4313964
GSM549104patient 119, normal, homogenized [OPG study]7.6619478
GSM549108patient 138, normal, homogenized [OPG study]6.728569
GSM549119patient 077, normal, homogenized [OPG study]6.4562765
GSM549133patient 032, cancer, homogenized [OPG study]7.0759672
GSM549139patient 042, cancer, homogenized [OPG study]6.6857268
GSM549099patient 107, normal, homogenized [OPG study]7.1251774
GSM549109patient 139, normal, homogenized [OPG study]7.0773773
GSM549110patient 046, normal, homogenized [OPG study]6.8395970
GSM549114patient 063, normal, homogenized [OPG study]7.6655778
GSM549122patient 082, normal, homogenized [OPG study]6.1121660
GSM549134patient 033, cancer, homogenized [OPG study]6.9966371
GSM549136patient 036, cancer, homogenized [OPG study]6.8786470
GSM549140patient 044, cancer, homogenized [OPG study]7.0663872
GSM549111patient 047, normal, homogenized [OPG study]7.3551975
GSM549113patient 057, normal, homogenized [OPG study]7.2624474
GSM549132patient 031, cancer, homogenized [OPG study]6.6822167
GSM549137patient 038, cancer, homogenized [OPG study]6.5502966
GSM549142patient 047, cancer, homogenized [OPG study]6.8454270
GSM549100patient 110, normal, homogenized [OPG study]6.8153170
GSM549107patient 135, normal, homogenized [OPG study]7.1831373
GSM549115patient 068, normal, homogenized [OPG study]7.1909173
GSM549116patient 072, normal, homogenized [OPG study]6.7239468
GSM549120patient 078, normal, homogenized [OPG study]7.0164272
GSM549131patient 030, cancer, homogenized [OPG study]6.9283570
GSM549118patient 074, normal, homogenized [OPG study]6.8555970
GSM549129patient 027, cancer, homogenized [OPG study]6.4948865
GSM549123patient 088, normal, homogenized [OPG study]6.9137970
GSM549124patient 006, cancer, homogenized [OPG study]6.0937559
GSM549126patient 015, cancer, homogenized [OPG study]7.4115676
GSM549128patient 025, cancer, homogenized [OPG study]6.8801269
GSM549103patient 117, normal, homogenized [OPG study]6.3122863
GSM549117patient 073, normal, homogenized [OPG study]7.1891874
GSM549138patient 041, cancer, homogenized [OPG study]6.2246461
GSM549141patient 045, cancer, homogenized [OPG study]6.389963
GSM549130patient 028, cancer, homogenized [OPG study]6.2495662
GSM549101patient 111, normal, homogenized [OPG study]7.2165574
GSM549105patient 128, normal, homogenized [OPG study]7.0067472
GSM549106patient 134, normal, homogenized [OPG study]8.0381380
GSM549112patient 048, normal, homogenized [OPG study]6.5105466
GSM549125patient 011, cancer, homogenized [OPG study]6.7715869
GSM549127patient 024, cancer, homogenized [OPG study]7.2934474
GSM549135patient 035, cancer, homogenized [OPG study]6.3905664